4
Changes in Ownership
WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001562180-23-003795
SVP, Chief Technology Officer sold 8,020 shares at an average $365.60 ($2,932,117)
- SVP, Chief Technology Officer acquired 8,020 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abraham Silji SVP, Chief Technology Officer | 2023-05-01 | Option exercise | +8,020 | $86.24 | $691,645 | 12,229.3 | D |
| Abraham Silji SVP, Chief Technology Officer | 2023-05-01 | Sale | −7,371 | $365.55 | $2,694,493 | 4,858.3 | D |
| Abraham Silji SVP, Chief Technology Officer | 2023-05-01 | Sale | −649 | $366.14 | $237,624 | 4,209.3 | D |
| Derivatives | |||||||
| Abraham Silji SVP, Chief Technology Officer | 2023-05-01 | Option exercise · Stock Options (Right to Buy) | −8,020 | 0 | D | ||
| Open-market sales · 8,020 sh · avg $365.60 · $2,932,117 | |||||||
Loading xslF345X04/primarydocument.xml…